Shkreli Resigns As Turing CEO After Securities Fraud Arrest
TRENTON, N.J. (CBSNewYork/AP) -- Martin Shkreli, the pharmaceutical executive arrested Thursday on charges of securities fraud related to a company he previously ran, has resigned as the head of one of the companies he now runs, Turing Pharmaceuticals.
He's being replaced on an interim basis by Ron Tilles, who has been chairman of Turing's board of directors since the company was founded late last year. In a statement Friday, Turing said that Tilles will continue to hold the board chairman position as well.
Tilles has worked at numerous private equity and venture capital firms in the pharmaceutical and medical device industries over the last two decades.
Shkreli, a 32-year-old former hedge fund manager, has become "the most hated man in America,'' according to some headline writers, for jacking up the price of the only approved drug for a life-saving parasitic infection by 5,000 percent after acquiring rights to it.
On Thursday, federal prosecutors said that between 2009 and 2014, Shkreli lost some of his hedge fund investors' money through bad trades, then looted Retrophin, a pharmaceutical company where he was CEO, for $11 million to pay back his disgruntled clients.
U.S. Attorney Robert Capers said in a statement that Shkreli, "engaged in multiple schemes to ensnare investors through a web of lies and deceit."
PHOTOS: Martin Shkreli Busted For Securities Fraud
Shkreli, a flagrant self-promoter who recently said he should have hiked the price of anti-parasitic drug Daraprim even more, was paraded in handcuffs by the FBI after his arrest.
A seven-count indictment was later unsealed in Brooklyn federal court.
Shkreli pleaded not guilty to charges of securities fraud and conspiracy, which carry a sentence of up to 20 years in prison if he's convicted.
He was released on $5 million bail. Shkreli also forfeited his passport and had his travel restricted to the Eastern and Southern districts of New York – an area that includes the five boroughs of New York City, Long Island and the north suburban counties.
A second defendant, lawyer Evan Greebel of Scarsdale, was charged with conspiracy and also pleaded not guilty.
The news, unrelated to his actions at Turing, delighted patients, advocacy groups and average Joes who found his price-gouging despicable.
Turing has offices in New York and Zug, Switzerland.
Shkreli recently became the CEO of a second company, KaloBios Pharmaceuticals, Inc., based in South San Francisco, California. There's no word yet on whether he'll remain at the helm there.
(TM and © Copyright 2015 CBS Radio Inc. and its relevant subsidiaries. CBS RADIO and EYE Logo TM and Copyright 2015 CBS Broadcasting Inc. Used under license. All Rights Reserved. This material may not be published, broadcast, rewritten, or redistributed. The Associated Press contributed to this report.)
